
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
CD4+ helper T cells endow cDC1 with cancer-impeding functions in the human tumor micro-environment
Xin Lei, Indu Khatri, Tom de Wit, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Xin Lei, Indu Khatri, Tom de Wit, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Showing 1-25 of 44 citing articles:
Dendritic cells as orchestrators of anticancer immunity and immunotherapy
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Ignacio Heras‐Murillo, Irene Adán‐Barrientos, Miguel Á. Galán, et al.
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 257-277
Closed Access | Times Cited: 105
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Jonathan H. Chen, Linda T. Nieman, Maxwell Spurrell, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 644-658
Open Access | Times Cited: 51
Jonathan H. Chen, Linda T. Nieman, Maxwell Spurrell, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 644-658
Open Access | Times Cited: 51
Trial watch: chemotherapy-induced immunogenic cell death in oncology
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Jenny Sprooten, Raquel S. Laureano, Isaure Vanmeerbeek, et al.
OncoImmunology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 45
Investigating the Dynamic Interplay Between Cellular Immunity and Tumor Cells in the Fight Against Cancer: An Updated Comprehensive Review
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 32
Seyed Ali Aghapour, Mehdi Torabizadeh, Seyed Sobhan Bahreiny, et al.
Iranian Journal of Blood and Cancer (2024) Vol. 16, Iss. 2, pp. 84-101
Closed Access | Times Cited: 32
CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses
Emma Grace Bawden, Teagan Wagner, Jan Schröder, et al.
Science Immunology (2024) Vol. 9, Iss. 91
Closed Access | Times Cited: 20
Emma Grace Bawden, Teagan Wagner, Jan Schröder, et al.
Science Immunology (2024) Vol. 9, Iss. 91
Closed Access | Times Cited: 20
CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors
Xin Lei, Daniël C. de Groot, Marij J.P. Welters, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 374-392
Open Access | Times Cited: 18
Xin Lei, Daniël C. de Groot, Marij J.P. Welters, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 374-392
Open Access | Times Cited: 18
Harnessing the tumor microenvironment: targeted cancer therapies through modulation of epithelial-mesenchymal transition
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Antonino Glaviano, Hannah Lau, Lukas M. Carter, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 12
Neoantigen-specific stem cell memory-like CD4+ T cells mediate CD8+ T cell-dependent immunotherapy of MHC class II-negative solid tumors
Spencer E. Brightman, Angelica Becker, Rukman R. Thota, et al.
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1345-1357
Open Access | Times Cited: 38
Spencer E. Brightman, Angelica Becker, Rukman R. Thota, et al.
Nature Immunology (2023) Vol. 24, Iss. 8, pp. 1345-1357
Open Access | Times Cited: 38
Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy
Alice Benoit, Guillaume Vogin, Caroline Duhem, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1787-1787
Open Access | Times Cited: 23
Alice Benoit, Guillaume Vogin, Caroline Duhem, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1787-1787
Open Access | Times Cited: 23
Architects of immunity: How dendritic cells shape CD8 + T cell fate in cancer
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
Vidit Bhandarkar, Teresa Dinter, Stefani Spranger
Science Immunology (2025) Vol. 10, Iss. 103
Closed Access | Times Cited: 1
Deciphering mechanical cues in the microenvironment: from non-malignant settings to tumor progression
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Yi‐Cheng Zhu, Jiaoshun Chen, Chen Chen, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1
CMTM6 shapes antitumor T cell response through modulating protein expression of CD58 and PD-L1
Beiping Miao, Zhaoqing Hu, Riccardo Mezzadra, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1817-1828.e9
Open Access | Times Cited: 22
Beiping Miao, Zhaoqing Hu, Riccardo Mezzadra, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1817-1828.e9
Open Access | Times Cited: 22
Spatial analysis of human lung cancer reveals organized immune hubs enriched for stem-like CD8 T cells and associated with immunotherapy response
Jonathan H. Chen, Linda T. Nieman, Maxwell Spurrell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 17
Jonathan H. Chen, Linda T. Nieman, Maxwell Spurrell, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 17
Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: a systematic review and meta-analysis
Xiaoqing Cao, Yaxin Kang, Ping Tai, et al.
Clinics and Research in Hepatology and Gastroenterology (2024), pp. 102510-102510
Closed Access | Times Cited: 6
Xiaoqing Cao, Yaxin Kang, Ping Tai, et al.
Clinics and Research in Hepatology and Gastroenterology (2024), pp. 102510-102510
Closed Access | Times Cited: 6
Small Molecule Targeting Immune Cells: A Novel Approach for Cancer Treatment
Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2621-2621
Open Access | Times Cited: 14
Shilpi Singh, Debashis Barik, Ananta Prasad Arukha, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2621-2621
Open Access | Times Cited: 14
Rintatolimod in Advanced Pancreatic Cancer Enhances Antitumor Immunity through Dendritic Cell–Mediated T-Cell Responses
Casper W.F. van Eijck, Hassana el Haddaoui, Songul Kucukcelebi, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 16, pp. 3447-3458
Closed Access | Times Cited: 5
Casper W.F. van Eijck, Hassana el Haddaoui, Songul Kucukcelebi, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 16, pp. 3447-3458
Closed Access | Times Cited: 5
Mechanisms of tumor immunosuppressive microenvironment formation in esophageal cancer
Xiaojun Zhang, Yan Yu, Heping Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 16, pp. 2195-2208
Open Access | Times Cited: 5
Xiaojun Zhang, Yan Yu, Heping Zhao, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 16, pp. 2195-2208
Open Access | Times Cited: 5
TIMP-1 is an activator of MHC-I expression in myeloid dendritic cells with implications for tumor immunogenicity
Miriam Langguth, Eleftheria Maranou, Saara A. Koskela, et al.
Genes and Immunity (2024) Vol. 25, Iss. 3, pp. 188-200
Open Access | Times Cited: 5
Miriam Langguth, Eleftheria Maranou, Saara A. Koskela, et al.
Genes and Immunity (2024) Vol. 25, Iss. 3, pp. 188-200
Open Access | Times Cited: 5
The epigenetic hallmarks of immune cells in cancer
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Ji Yu, Chu Xiao, Tao Fan, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
RBBP8 Is a Prognostic Biomarker Associated With Response to Immune Checkpoint Inhibitors in Advanced Gastric Cancer
Taiki Nakashima, Ryu Matsumoto, Kiyonori Tanoue, et al.
Journal of Immunotherapy (2025)
Closed Access
Taiki Nakashima, Ryu Matsumoto, Kiyonori Tanoue, et al.
Journal of Immunotherapy (2025)
Closed Access
Tissue-specific properties of type 1 dendritic cells in lung cancer: implications for immunotherapy
Laura Rodríguez, Roberto M. Amadio, Giulia Maria Piperno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010547-e010547
Open Access
Laura Rodríguez, Roberto M. Amadio, Giulia Maria Piperno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010547-e010547
Open Access
Myeloid cells are involved in tumor immunity, metastasis and metabolism in tumor microenvironment
Chun Zhang, Ying Song, Huanming Yang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
Chun Zhang, Ying Song, Huanming Yang, et al.
Cell Biology and Toxicology (2025) Vol. 41, Iss. 1
Open Access
The role of immunotherapy in targeting tumor microenvironment in genitourinary cancers
Ecem Kalemoglu, Yash Jani, Kübra Canaslan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Ecem Kalemoglu, Yash Jani, Kübra Canaslan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Immunotherapy with conventional type-1 dendritic cells induces immune memory and limits tumor relapse
Ignacio Heras‐Murillo, Diego Mañanes, Pablo Munné, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Ignacio Heras‐Murillo, Diego Mañanes, Pablo Munné, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
The diversity of CD8+ T cell dysfunction in cancer and viral infection
Lorenzo Galluzzi, Kellie N. Smith, Adrian Liston, et al.
Nature reviews. Immunology (2025)
Closed Access
Lorenzo Galluzzi, Kellie N. Smith, Adrian Liston, et al.
Nature reviews. Immunology (2025)
Closed Access